Holds 2 active US DMFs and 2 valid CEPs for clonidine, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds 2 active US DMFs and 2 valid CEPs for clonidine, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds one valid CEP for clonidine, filing since 2024. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 13 markets.
Holds one active US DMF for clonidine, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds 2 active US DMFs for clonidine, filing since 2017. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for clonidine, filing since 1983. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for clonidine, filing since 2010. Its 2023 FDA inspection closed as VAI.
Holds 2 active US DMFs for clonidine, filing since 1982.
Holds one valid CEP for clonidine, filing since 2022.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free